Similar articles for PMID: 31216733

Year	Number of Results
1986	2
1988	1
1989	1
1990	4
1991	2
1993	1
1996	2
1997	2
2000	2
2002	1
2003	1
2006	1
2007	3
2008	1
2009	2
2010	2
2011	3
2012	3
2013	7
2014	4
2015	7
2016	12
2017	10
2018	13
2019	4
2021	2
2022	2
2023	1
2024	0

1

Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin.

Miyake M, Hori S, Ohnishi S, Owari T, Iida K, Ohnishi K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Fujii T, Tanaka N, Fujimoto K. Miyake M, et al. Diseases. 2019 Jun 18;7(2):44. doi: 10.3390/diseases7020044. Diseases. 2019. PMID: 31216733 Free PMC article.

2

Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.

Chevalier MF, Schneider AK, Cesson V, Dartiguenave F, Lucca I, Jichlinski P, Nardelli-Haefliger D, Derré L. Chevalier MF, et al. Eur Urol. 2018 Nov;74(5):540-544. doi: 10.1016/j.eururo.2018.06.045. Epub 2018 Jul 19. Eur Urol. 2018. PMID: 30033046

3

Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin.

Hashizume A, Umemoto S, Yokose T, Nakamura Y, Yoshihara M, Shoji K, Wada S, Miyagi Y, Kishida T, Sasada T. Hashizume A, et al. Oncotarget. 2018 Sep 25;9(75):34066-34078. doi: 10.18632/oncotarget.26122. eCollection 2018 Sep 25. Oncotarget. 2018. PMID: 30344922 Free PMC article.

4

Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.

Miyake M, Tatsumi Y, Gotoh D, Ohnishi S, Owari T, Iida K, Ohnishi K, Hori S, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Shimada K, Konishi N, Tanaka N, Fujimoto K. Miyake M, et al. Int J Mol Sci. 2017 Oct 19;18(10):2186. doi: 10.3390/ijms18102186. Int J Mol Sci. 2017. PMID: 29048388 Free PMC article.

5

Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.

Chou R, Selph S, Buckley DI, Fu R, Griffin JC, Grusing S, Gore JL. Chou R, et al. J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24. J Urol. 2017. PMID: 28027868

6

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin.

De Boer EC, De Jong WH, Van Der Meijden AP, Steerenberg PA, Witjes JA, Vegt PD, Debruyne FM, Ruitenberg EJ. De Boer EC, et al. Cancer Immunol Immunother. 1991;33(6):411-6. doi: 10.1007/BF01741603. Cancer Immunol Immunother. 1991. PMID: 1878894

7

Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.

Derré L, Cesson V, Lucca I, Cerantola Y, Valerio M, Fritschi U, Vlamopoulos Y, Burruni R, Legris AS, Dartiguenave F, Gharbi D, Martin V, Vaucher L, Speiser DE, Romero P, Jichlinski P, Nardelli-Haefliger D. Derré L, et al. Clin Cancer Res. 2017 Feb 1;23(3):717-725. doi: 10.1158/1078-0432.CCR-16-1189. Epub 2016 Aug 12. Clin Cancer Res. 2017. PMID: 27521445 Clinical Trial.

8

Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.

Takayama H, Nishimura K, Tsujimura A, Nakai Y, Nakayama M, Aozasa K, Okuyama A, Nonomura N. Takayama H, et al. J Urol. 2009 Apr;181(4):1894-900. doi: 10.1016/j.juro.2008.11.090. Epub 2009 Feb 23. J Urol. 2009. PMID: 19237175

9

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.

de Reijke TM, de Boer EC, Kurth KH, Schamhart DH. de Reijke TM, et al. J Urol. 1996 Feb;155(2):477-82. J Urol. 1996. PMID: 8558640 Clinical Trial.

10

Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.

Giannarini G, Birkhäuser FD, Recker F, Thalmann GN, Studer UE. Giannarini G, et al. Eur Urol. 2014 Apr;65(4):825-31. doi: 10.1016/j.eururo.2013.09.049. Epub 2013 Oct 9. Eur Urol. 2014. PMID: 24144432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year